Martin A. Vogelbaum's most recent trade in Tvardi Therapeutics Inc. was a trade of 390,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 390,000 | 390,000 | - | - | Stock Option (Right to Buy) | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 301,295 | 411,007 (0%) | 0% | 0 | Common Stock | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 89,923 | 89,923 | - | - | Stock Option (Right to Buy) | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 64,724 | 109,712 (0%) | 0% | 0 | Common Stock | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Sale of securities on an exchange or to another person at price $ 10.28 per share. | 14 Sep 2022 | 10,800 | 44,988 (0%) | 0% | 10.3 | 111,024 | Common Stock |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 33,993 | 33,993 | - | - | Stock Option (Right to Buy) | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 23,752 | 43,912 (0%) | 0% | 0 | Common Stock | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,876 | 55,788 (0%) | 0% | 0 | Common Stock | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 21,600 | 21,600 | - | - | Stock Option (Right to Buy) | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 14,400 | 28,800 (0%) | 0% | 0 | Common Stock | |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 03 Jun 2021 | 8,640 | 20,160 (0%) | 0% | 13.1 | 112,752 | Common Stock |
Tvardi Therapeutics Inc. | Martin A. Vogelbaum | Director | Sale of securities on an exchange or to another person at price $ 16.09 per share. | 17 Nov 2020 | 6,000 | 14,400 (0%) | 0% | 16.1 | 96,540 | Common Stock |